Search

Author/Creator Sydes, Matthew R

3. Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol. Issue 10323 (29th January 2022)

Authors:
Attard, Gerhardt; Murphy, Laura; Clarke, Noel W; Cross, William; Jones, Robert J; Parker, Christopher C; Gillessen, Silke; Cook, Adrian; Brawley, Chris; Amos, Claire L; Atako, Nafisah; Pugh, Cheryl; Buckner, Michelle; Chowdhury, Simon; Malik, Zafar; Russell, J Martin; Gilson, Clare; Rush, Hannah;...
Journal:
Lancet
Issue:
Volume 399:Issue 10323(2022)
Page Start:
447
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Addition of docetaxel or bisphosphonates to standard of care in men with localised or metastatic, hormone-sensitive prostate cancer: a systematic review and meta-analyses of aggregate data. Issue 2 (February 2016)

Authors:
Vale, Claire L; Burdett, Sarah; Rydzewska, Larysa H M; Albiges, Laurence; Clarke, Noel W; Fisher, David; Fizazi, Karim; Gravis, Gwenaelle; James, Nicholas D; Mason, Malcolm D; Parmar, Mahesh K B; Sweeney, Christopher J; Sydes, Matthew R; Tombal, Bertrand; Tierney, Jayne F
Journal:
Lancet oncology
Issue:
Volume 17:Issue 2(2016:Feb.)
Page Start:
243
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial. Issue 10024 (19th March 2016)

Authors:
James, Nicholas D; Sydes, Matthew R; Clarke, Noel W; Mason, Malcolm D; Dearnaley, David P; Spears, Melissa R; Ritchie, Alastair W S; Parker, Christopher C; Russell, J Martin; Attard, Gerhardt; de Bono, Johann; Cross, William; Jones, Rob J; Thalmann, George; Amos, Claire; Matheson, David; Millman,...
Journal:
Lancet
Issue:
Volume 387:Issue 10024(2016)
Page Start:
1163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data. Issue 10260 (31st October 2020)

Authors:
Vale, Claire L; Fisher, David; Kneebone, Andrew; Parker, Christopher; Pearse, Maria; Richaud, Pierre; Sargos, Paul; Sydes, Matthew R; Brawley, Christopher; Brihoum, Meryem; Brown, Chris; Chabaud, Sylvie; Cook, Adrian; Forcat, Silvia; Fraser-Browne, Carol; Latorzeff, Igor; Parmar, Mahesh K B; Tier...
Journal:
Lancet
Issue:
Volume 396:Issue 10260(2020)
Page Start:
1422
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial. Issue 10 (October 2016)

Authors:
Marina, Neyssa M; Smeland, Sigbjørn; Bielack, Stefan S; Bernstein, Mark; Jovic, Gordana; Krailo, Mark D; Hook, Jane M; Arndt, Carola; van den Berg, Henk; Brennan, Bernadette; Brichard, Bénédicte; Brown, Ken L B; Butterfass-Bahloul, Trude; Calaminus, Gabriele; Daldrup-Link, Heike E; Eriksson, Mika...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 10(2016:Oct.)
Page Start:
1396
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗